Therapeutic Potential Inc Bradenton, FL - 34202

Therapeutic Potential Inc is categorized under Speech Pathologists in Bradenton, FL and active since 2002.

Therapeutic Potential Inc was established in 2002, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Speech Pathologists business, which does work in the B2C market, and is classified as a Speech Pathologists, under code number 621340 by the NAICS.

If you are seeking more information, feel free to contact Ray Colombo at the company’s single location by writing to 9020 58th Drive East # 102, Bradenton, Florida FL 34202 or by phoning (941) 758-3140. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Therapeutic Potential Inc
Contact Person: Ray Colombo
Address: 9020 58th Drive East # 102, Bradenton, Florida 34202
Phone Number: (941) 758-3140
Website Address: tpikids.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2002
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Speech Pathologists
SIC Code: 8049
NAICS Code: 621340
Share This Business:

Therapeutic Potential Inc was started in 2002 to provide professional Speech Pathologists under the SIC code 8049 and NAICS code 621340. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Ray Colombo for inquiries that concern Therapeutic Potential Inc by calling the company number (941) 758-3140, as your correspondence is most welcome. Additionally, the physical location of the single location of Therapeutic Potential Inc can be found at the coordinates 27.436458,-82.447896 as well as the street address 9020 58th Drive East # 102 in Bradenton, Florida 34202.

For its online presence, you may visit Therapeutic Potential Inc’s website at tpikids.com and engage with its social media outlets through on Twitter and on Facebook.